Model MADgic -Malleable Topical Anaesthetic Drug Delivery Device
The MADgic™ Laryngo-Tracheal Mucosal Atomization Device from Teleflex offers a versatile choice to administer topical anesthesia across the entire upper airway and beyond the vocal cords. This helps to suppress the airway responses to emergence phenomena such as coughing or laryngospasm and reduce the cardiovascular responses. The malleable stylet enables precise, targeted delivery specific to patient`s anatomy. Consistent, fine atomized spray for direct coverage of nose, pharynx, larynx and trachea, Targeted Coverage – narrow, long stylet easily reaches vocal cords and conforms to patient anatomy, Adapts to any luer-lock syringe, Clinician chooses the medication and exact dose and volume (down to 0.1 mL), Available in adult and pediatric sizes.
An atraumatic device for the delivery of topical anaesthetic in paediatric patients
The use of MADgic™ to deliver topical anaesthesia to the upper airway increases patient acceptance during difficult awake intubations. Topical anaesthesia can also reduce the risk of laryngospasm vs intravenous drug delivery.
Larygospasms are three times more likely to occur in a paediatric patient than an adult.
Utilising MADgic™ to apply topical anaesthetic:
- May reduce coughing or gagging versus intravenous delivery of anaesthetic
- Replaces the need to deliver anaesthetic via the cricothyroid ligament
Benefits of topical anaesthetic delivered via MADgic™
MADgic™ is a device that has the ability to deliver atomized topical anaesthesia directly to the airway mucosa to suppress airway responses to stimulation and facilitate tracheal intubation. This may avoid the need to use neuromuscular blockers before intubation.
Topical anaesthetic delivered via MADgic™ has been shown to:
An ideal topical anesthetic should have rapid onset, adequate duration, and minimal or predictable systemic absorption, with the ability to be accurately administered.